To further validate the link between β-catenin and G6PD-mediated anti-ROS generation in Dexa-resistant cells, we examined the changes in ROS levels by adding Wnt3a to MM cells with or without RRX-001 treatment. Here, WNT3A is linked to Miyoshi myopathy.